Cargando…
Frailty and the Risk of Polypharmacy in the Older Person: Enabling and Preventative Approaches
Frail older people have an inherent risk of polypharmacy due to the need to treat multiple comorbidities, thus leading to various negative effects on their health due to the adverse actions from the drugs. This issue was discussed from a person-centered perspective, highlighting the category of frai...
Autor principal: | Nwadiugwu, Martin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341397/ https://www.ncbi.nlm.nih.gov/pubmed/32676209 http://dx.doi.org/10.1155/2020/6759521 |
Ejemplares similares
-
Multi-Morbidity in the Older Person: An Examination of Polypharmacy and Socioeconomic Status
por: Nwadiugwu, Martin C.
Publicado: (2021) -
The Need for Actions Against Polypharmacy in Older People With Frailty
por: Kojima, Taro
Publicado: (2018) -
Drug storage, polypharmacy and frailty syndrome in older people: an observational study
por: Tabué-Téguo, Maturin, et al.
Publicado: (2023) -
Polypharmacy, comorbidity and frailty: a complex interplay in older patients at the emergency department
por: van Dam, Carmen S., et al.
Publicado: (2022) -
POLYPHARMACY, FRAILTY, AND DISABILITY-FREE SURVIVAL IN COMMUNITY-DWELLING HEALTHY OLDER INDIVIDUALS
por: Ekram, A R M Saifuddin, et al.
Publicado: (2022)